Adrenergic signaling plays a critical role in the maintenance of waking and in the regulation of REM sleep

Journal of Neurophysiology

Volumn 92, Issue 4, 2004, Pages 2071-2082

  Ouyang, Ming ^a   Hellman, Kevin ^a   Abel, Ted ^a   Thomas, Steven A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; NORADRENALIN;

ADOLESCENT; ADRENERGIC SYSTEM; AGED; ANIMAL EXPERIMENT; AROUSAL; ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; GENE DISRUPTION; HOMEOSTASIS; MALE; MOUSE; MOUSE MUTANT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REBOUND; REGULATORY MECHANISM; REM SLEEP; SLEEP DEPRIVATION; SLEEP TIME; SLEEP WAKING CYCLE; WAKEFULNESS;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; DOPAMINE BETA-HYDROXYLASE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EPINEPHRINE; FEMALE; GENOTYPE; HOMEOSTASIS; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NOREPINEPHRINE; PHENOTYPE; RECEPTORS, ADRENERGIC, ALPHA-1; SLEEP DEPRIVATION; SLEEP, REM; SYMPATHETIC NERVOUS SYSTEM; WAKEFULNESS;

EID: 4644256511     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00226.2004     Document Type: Article

References (87)

1. Abercrombie ED and Zigmond MJ. Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. J Neurosci 9: 4062-4067, 1989.
2. Acheson AL, Zigmond MJ, and Stricker EM. Compensatory increase in tyrosine hydroxylase activity in rat brain after intraventricular injections of 6-hydroxydopamine. Science 207: 537-540, 1980.
3. Allain P and Krari N. Diethyldithiocarbamate, copper, and neurological disorders. Life Sci 48: 291-299, 1991.
4. Aston-Jones G and Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1: 876-886, 1981.
5. Aston-Jones G, Chen S, Zhu Y, and Oshinsky ML. A neural circuit for circadian regulation of arousal. Nat Neurosci 4: 732-738, 2001.
6. Benington JH and Heller HC. Monoaminergic and cholinergic modulation of REM-sleep timing in rats. Brain Res 681: 141-146, 1995.
7. Benington JH, Kodali SK, and Heller HC. Scoring transitions to REM sleep in rats based on the EEG phenomena of pre-REM sleep: an improved analysis of sleep structure. Sleep 17: 28-36, 1994.
8. Berridge CW and Espana RA. Synergistic sedative effects of noradrenergic alpha(1)- and beta-receptor blockade on forebrain electroencephalographic and behavioral indices. Neuroscience 99: 495-505, 2000.
9. Berridge CW and Foote SL. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 11: 3135-3145, 1991.
10. Berridge CW and Foote SL. Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. J Neurosci 16: 6999-7009, 1996.
11. Berridge CW and O'Neill J. Differential sensitivity to the wake-promoting actions of norepinephrine within the medial preoptic area and the substantia innominate. Behav Neurosci 115: 165-174, 2001.
12. Berridge CW, Page ME, Valentine RJ, and Foote SL. Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience 55: 381-393, 1993.
13. Berridge CW and Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42: 33-84, 2003.
14. Betts TA and Alford C. Beta-blockers and sleep: a controlled trial. Eur J Clin Pharmacol 28: 65-68, 1985.
15. Borbely AA. A two process model of sleep regulation. Hum Neurobiol 1: 195-204, 1982.
16. Cape EG and Jones BE. Differential modulation of high-frequency gamma-electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons. J Neurosci 18: 2653-2666, 1998.
17. Chemelli MM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451, 1999.
18. Chiodo LA, Acheson AL, Zigmond MJ, and Stricker EM. Subtotal destruction of central noradrenergic projections increases the firing rate of locus coeruleus cells. Brain Res 264: 123-126, 1983.
19. Cirelli C, Pompeiano M, and Tononi G. Neuronal gene expression in the waking state: a role for the locus coeruleus. Science 274: 1211-1215, 1996.
20. Cirelli C and Tononi G. Differential expression of plasticity-related genes in waking and sleep and their regulation by the noradrenergic system. J Neurosci 20: 9187-9194, 2000.
21. Cordeau JP, De Champlain J, and Jacks B. Excitation and prolonged waking produced by catecholamines injected into the ventricular system of cats. Can J Physiol Pharmacol 49: 627-631, 1971.
22. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS, 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, and Sutcliffe JG. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322-327, 1998.
23. Delagrange P, Tadjer D, Bouyer JJ, Rougeul A, and Conrath M. Effect of DSP4, a neurotoxic agent, on attentive behavior and related electrocortical activity in cat. Behav Brain Res 33: 33-43, 1989.
24. Delmaestro E and Trombetta LD. The effects of disulfiram on the hippocampus and cerebellum of the rat brain: a study on oxidative stress. Toxicol Lett 75: 235-243, 1995.
25. Diggle P, Liang K-Y, and Zeger S. Analysis of longitudinal data. In: Oxford Statistical Science Series 25 (2nd ed.). Oxford, UK: Oxford University Press, 2002.
26. Feldberg W and Sherwood SL. Injections of drugs into the lateral ventrical of the cat. J Physiol 123: 148-167, 1954.
27. Foote SL, Aston-Jones G, and Bloom FE. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl Acad Sci USA 77: 3033-3037, 1980.
28. Franken P, Malafosse A, and Tafti M. Genetic determinants of sleep regulation in inbred mice. Sleep 22: 155-169, 1999.
29. Franken P, Malafosse A, and Tafti M. Genetic variation in EEG activity during sleep in inbred mice. Am J Physiol Regulatory Integrative Comp Physiol 275: R1127-1137, 1998.
30. Gage FH, Bjorklund A, and Stenevi U. Local regulation of compensatory noradrenergic hyperactivity in the partially denervated hippocampus. Nature 303: 819-821, 1983.
31. Gallopin T, Fort P, Eggermann E, Cauli B, Luppi PH, Rossier J, Audinat E, Muhlethaler M, and Serafin M. Identification of sleep-promoting neurons in vitro. Nature 404: 992-995, 2000.
32. Gonzalez MM, Debilly G, and Valatx JL. Noradrenaline neurotoxin DSP-4 effects on sleep and brain temperature in the rat. Neurosci Lett 248: 93-96, 1998.
33. Gonzalez MM, Valatx JL, and Debilly G. Role of the locus coeruleus in the sleep rebound following two different sleep deprivation methods in the rat. Brain Res 740: 215-226, 1996.
34. Grassi Zucconi G, Semprevivo M, Laurenzi MA, and Giuditta A. Sleep impairment by diethyldithiocarbamate in rat. Protective effects of preconditioning and antioxidants. Brain Res 939: 87-94, 2002.
35. Graves LA, Hellman K, Veasey S, Blendy JA, Pack AI, and Abel T. Genetic evidence for a role of CREB in sustained cortical arousal. J Neurophysiol 90: 1152-1159, 2003.
36. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P, Munton RP, Ashmeade TE, Shah AS, Hatcher JP, Hatcher PD, Jones DN, Smith MI, Piper DC, Hunter AJ, Porter RA, and Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 96: 10911-10916, 1999.
37. Haley TJ and McCormick WG. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12: 12-15, 1957.
38. Hansen MG and Whishaw IQ. The effects of 6-hydroxydopamine, dopamine and dl-norepinephrine on food intake and water consumption, self-stimulation, temperature and electroencephalographic activity in the rat. Psychopharmacologia 29: 33-44, 1973.
39. Hartmann E, Chung R, Draskoczy PR, and Schildkraut JJ. Effects of 6-hydroxydopamine on sleep in the rat. Nature 233: 425-427, 1971.
40. Hilakivi I. The role of beta- and alpha-adrenoceptors in the regulation of the stages of the sleep-waking cycle in the cat. Brain Res 277: 109-118, 1983.
41. Hilakivi I and Leppavuori A. Effects of methoxamine, and alpha-1 adrenoceptor agonist, and prazosin, an alpha-1 antagonist, on the stages of the sleep-waking cycle in the cat. Acta Physiol Scand 120: 363-372, 1984.
42. Hobson JA, McCarley RW, and Wyzinski PW. Sleep cycle oscillation: reciprocal discharge by two brain stem neuronal groups. Science 189: 55-58, 1975.
43. Hoffman BB and Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Goodman and Gilman's the Pharmacological Basis of Therapeutics (9th ed.), edited by Goodman LS, Gilman A, Hardman JG, and Limbird LE. New York: McGraw-Hill Health Professions Division, 1996, p. 199-248.
44. Howard JL and Breese GR. Physiological and behavioral effects of centrally administered 6-hydroxydopamine in cats. Pharmacol Biochem Behav 2: 651-661, 1974.
45. Hughes ZA and Stanford SC. A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo. Psychopharmacology 136: 299-303, 1998.
46. Hunsley MS and Palmiter RD. Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine. Sleep 26: 521-526, 2003.
47. Itil TM and Itil KZ. Central mechanisms of clonidine and propranolol in man. Quantitative Pharmaco-EEG with antihypertensive compounds. Chest 83: 411-416, 1983.
48. Jin S-H, Kim HJT, Harris DC, and Thomas SA. Postnatal development of the cerebellum and the CNS adrenergic system is independent of norepinephrine and epinephrine. J Comp Neurol. In press.
49. Jones BE, Bobillier P, Pin C, and Jouvet M. The effect of lesions of catecholamine-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat. Brain Res 58: 157-177, 1973.
50. Jones BE, Harper ST, and Halaris AE. Effects of locus coeruleus lesions upon cerebral monoamine content, sleep-wakefulness states and the response to amphetamine in the cat. Brain Res 124: 473-496, 1977.
51. Jouvet M. Biogenic amines and the states of sleep. Science 163: 32-41, 1969.
52. Kleinlogel H. Effects of the selective alpha 1-adrenoceptor blocker prazosin on EEG sleep and waking stages in the rat. Neuropsychobiology 21: 100-103, 1989.
53. Kostis JB, Rosen RC, Holzer BC, Randolph C, Taska LS, and Miller MH. CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males. Psychopharmacology 102: 163-170, 1990.
54. Laguzzi R, Petitjean F, Pujol JF, and Jouvet M. Effects of the intraventricular injection of 6-hydroxydopamine on the sleep-waking cycle of the cat. Brain Res 48: 295-310, 1972.
55. Lanfumey L, Dugovic C, and Adrien J. Beta 1 and beta 2 adrenergic receptors: their role in the regulation of paradoxical sleep in the rat. Electroencephalogr Clin Neurophysiol 60: 558-567, 1985.
56. Leconte P and Hennevin E. Post-learning paradoxical sleep, reticular activation and noradrenergic activity. Physiol Behav 26: 587-594, 1981.
57. Lidbrink P. The effect of lesions of ascending noradrenaline pathways on sleep and waking in the rat. Brain Res 74: 19-40, 1974.
58. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, and Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98: 365-376, 1999.
59. Lu J, Greco MA, Shiromani P, and Saper CB. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 20: 3830-3842, 2000.
60. Makela JP and Hilakivi IT. Effect of alpha-adrenoceptor blockade on sleep and wakefulness in the rat. Pharmacol Biochem Behav 24: 613-616, 1986.
61. Mallick BN and Alam MN. Different types of norepinephrinergic receptors are involved in preoptic area mediated independent modulation of sleep-wakefulness and body temperature. Brain Res 591: 8-19, 1992.
62. Matsuda Y. Effects of intraventricularly administered adrenaline on rabbit's EEG and their modifications by adrenergic blocking agents. Jpn J Pharmacol 18: 139-152, 1968.
63. Matsuyama S, Coindet J, and Mouret J. Intracisternal 6-hydroxydopamine and sleep in the rat. Brain Res 57: 85-95, 1973.
64. McCormick DA, Pape HC, and Williamson A. Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog Brain Res 88: 293-305, 1991.
65. Monti JM, D'Angelo L, Jantos H, Barbeito L, and Abo V. Effect of DSP-4, a noradrenergic neurotoxin, on sleep and wakefulness and sensitivity to drugs acting on adrenergic receptors in the rat. Sleep 11: 370-377, 1988.
66. Morrison D. Applied Statistical Methods. Englewood Cliffs, NJ: Prentice-Hall, 1983.
67. Pace-Schott EF, and Hobson JA. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3: 591-605, 2002.
68. Palkovits M, Zaborszky L, Feminger A, Mezey E, Fekete MI, Herman JP, Kanyicska B, and Szabo D. Noradrenergic innervation of the rat hypothalamus:experimental biochemical and electron microscopic studies. Brain Res 191: 161-171, 1980.
69. Panksepp J, Jalowiec JE, Morgane PJ, Zolovick AJ, and Stern WC. Noradrenergic pathways and sleep-waking states in cats. Exp Neurol 41: 233-245, 1973.
70. Park SP. In vivo microdialysis measures of extracellular norepinephrine in the rat amygdala during sleep-wakefulness. J Korean Med Sci 17: 395-399, 2002.
71. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, and Lin JS. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22: 7695-7711, 2002.
72. Pellejero T, Monti JM, Baglietto J, Jantos H, Pazos S, Cichevski V, and Hawkins M. Effects of methoxamine and alpha-adrenoceptor antagonists, prazosin and yohimbine, on the sleep-wake cycle of the rat. Sleep 7: 365-372, 1984.
73. Roubicek J. Effect of beta-adrenoceptor blocking drugs on EEG. Br J Clin Pharmacol 3: 661-665, 1976.
74. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
75. Saper CB, Chou TC, and Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24: 726-731, 2001.
76. SAS. SAS OnlineDoc, Version 8: SAS Institute Inc, 1999.
77. Sherin JE, Shiromani PJ, McCarley RW, and Saper CB. Activation of ventrolateral preoptic neurons during sleep. Science 271: 216-219, 1996.
78. Shouse MN, Staba RJ, Saquib SF, and Farber PR. Monoamines and sleep: microdialysis findings in pons and amygdala. Brain Res 860: 181-189, 2000.
79. Singer J. Using SAS PROC.MIXED to fit multilevel models, hierarchical models, and individual growth models. J Educ Behav Stat 24: 323-355, 1998.
80. Thomas SA, Marck BT, Palmiter RD, and Matsumoto AM. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem 70: 2468-2476, 1998.
81. Thomas SA, Matsumoto AM, and Palmiter RD. Noradrenaline is essential for mouse fetal development. Nature 374: 643-646, 1995.
82. Torbati D. Effect of propranolol on cortical electrical activity in conscious and anesthetized rats. Neuropharmacology 25: 1251-1254, 1986.
83. Tulen JH, Man in 't Veld AJ, Dzoljic MR, Mechelse K, and Moleman P. Sleeping with and without norepinephrine: effects of metoclopramide and D,L-threo-3,4-dihydroxyphenylserine on sleep in dopamine beta-hydroxylase deficiency. Sleep 14: 32-38, 1991.
84. Tulen JH, Man in't Veld AJ, Mechelse K, and Boomsma F. Sleep patterns in congenital dopamine beta-hydroxylase deficiency. J Neurol 237: 98-102, 1990.
85. Veasey SC, Valladares O, Fenik P, Kapfhamer D, Sanford L, Benington J, and Bucan M. An automated system for recording and analysis of sleep in mice. Sleep 23: 1025-1040, 2000.
86. Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, Marcus JN, Lee C, Elmquist JK, Kohlmeier KA, Leonard CS, Richardson JA, Hammer RE, and Yanagisawa M. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 38: 715-730, 2003.
87. Zamboni G, Perez E, Amici R, and Parmeggiani PL. The short-term effects of dl-propranolol on the wake-sleep cycle of the rat are related to selective changes in preoptic cyclic AMP concentration. Exp Brain Res 81: 107-112, 1990.